Earendil Labs and WuXi Biologics Enter Strategic Collaboration to Accelerate Development and Manufacturing of Bispecific/Multispecific Antibodies and ADCs

Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and WuXi Biologics (2269.HK), a global leading Contract Research, Development and ...

Why AI Strategy Succeeds When Leaders Invest In People

AI transformation succeeds when leaders prioritize human-centric strategy over technical deployment to turn innovative tools into measurable productivity gains.

GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub

GenScript announced the official opening of its first European mRNA production site in Delft, the Netherlands, marking a significant expansion of the company's global mRNA platform and reinforcing ...
Pharmabiz

GenScript opens its first European mRNA production site in Delft, strengthens transatlantic biotechnology infrastructure

GenScript opens its first European mRNA production site in Delft, strengthens transatlantic biotechnology infrastructure: Delft, The Netherlands Saturday, March 14, 2026, 13:00 Hr ...
People’s Army Newspaper Online

Politburo, Secretariat announce inspection of Party Committee of Central Party Agencies

A conference was held in Hanoi on March 9 to announce a decision of the Politburo and the Secretariat to conduct inspection ...

ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:00 PM EDTCompany ParticipantsNikhil Lalwani - ...

Waldencast Reports Q4 2025 and FY 2025 Financial Results

FY 2025 net revenue of $272.1 million, flat to FY 2024, and Adjusted EBITDA of $16.1 millionQ4 2025 net revenue of $72.0 million, flat to Q4 2024 ...

Patrys starts manufacturing and regulatory work for RLS-2201 trial

Patrys Ltd (ASX:PAB) has begun manufacturing and regulatory activities for RLS-2201, its proprietary injectable quetiapine formulation being developed to treat delirium, as it works toward launching a ...

ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update

SAN DIEGO, March 10, 2026 (GLOBE NEWSWIRE) -- ImageneBio, Inc. (Nasdaq: IMA) (“Imagene” or the “Company”) today reported financial results for the fourth quarter and full year ended December 31, 2025, ...

Lifecore Biomedical Signs New Agreement with Indomo to Support Innovative Drug/Device Combination Acne Treatment

Detailed price information for Lifecore Biomedical Inc (LFCR-Q) from The Globe and Mail including charting and trades.

GenScript Biotech Corporation: GenScript Strengthens Transatlantic Biotech Infrastructure with European mRNA Hub

Strategic investment reinforces Europe as a core pillar of GenScript's global R&D and production network, following recent U.S. facility expansion.DELFT, Netherlands, March 12, 2026 /PRNewswire/ ...
Seeking Alpha

GSK plc (GSK) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Great. Thank you for coming, everybody. I'm James Gordon, Barclays European pharma and biotech analyst. And today, I've got the pleasure of hosting a fireside with GSK. So we're going to hear from GSK ...